The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, ...
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...
Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial LaunchStrategic Partner Bio-Rad Invests, Boosts Support for ...
Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with global ...
The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course" conference has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which ...
Global design and BIM software provider Vectorworks, Inc. has released its latest report, offering insights from hundreds of professionals into what the future has in store for the AEC industry. The ...
Tecan, the global leader in laboratory automation, today announced the unveiling of Veya™, a transformative liquid handling platform designed to bring efficiency, precision and compliance to ...
A blood-based IVD test that can quantify these biomarkers in plasma could provide a non-invasive, accessible, and earlier method of detecting Alzheimer’s-related pathology. This capability is ...
Walmart founder Sam Walton receiving the presidential Medal of Freedom award from president George H.W. Bush in 1992. © 2024 Fortune Media IP Limited. All Rights ...
Akoya Biosciences (AKYA) and Argonaut Manufacturing Services, a contract development and manufacturing organization serving the biopharma and ...
(“Akoya”), The Spatial Biology Company®, announced today that Argonaut will act as the manufacturing partner for Akoya’s IVD assays currently in development. This agreement builds on years ...